Chemoinformaics analysis of 2,6,10,15-TETRAMETHYLHEPTADECANE
Molecular Weight | 296.583 | nRot | 14 |
Heavy Atom Molecular Weight | 252.231 | nRig | 0 |
Exact Molecular Weight | 296.344 | nRing | 0 |
Solubility: LogS | -7.328 | nHRing | 0 |
Solubility: LogP | 9.185 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 65 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 44 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 64.4089 |
nHD | 0 | BPOL | 44.1411 |
QED | 0.286 |
Synth | 3.095 |
Natural Product Likeliness | 0.664 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.019 |
Pgp-sub | 0.001 |
HIA | 0.002 |
CACO-2 | -4.613 |
MDCK | 0.00000592 |
BBB | 0.358 |
PPB | 0.982589 |
VDSS | 3.012 |
FU | 0.01847 |
CYP1A2-inh | 0.163 |
CYP1A2-sub | 0.176 |
CYP2c19-inh | 0.252 |
CYP2c19-sub | 0.409 |
CYP2c9-inh | 0.222 |
CYP2c9-sub | 0.935 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.02 |
CYP3a4-inh | 0.17 |
CYP3a4-sub | 0.105 |
CL | 6.403 |
T12 | 0.022 |
hERG | 0.051 |
Ames | 0.005 |
ROA | 0.013 |
SkinSen | 0.948 |
Carcinogencity | 0.029 |
EI | 0.927 |
Respiratory | 0.125 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.610004 |